❮ Back to Researchers

Jiwon Oh

MD, PhD

Scientist

Email: Jiwon.Oh@unityhealth.to
Tel: 416-864-6060 ext. 2282

Research Programs

Biography

Research Interests

Multiple sclerosis (MS), MRI biomarkers with clinical utility in prognostication and disease monitoring, cohort studies

Research Activities

Jiwon Oh is a staff neurologist, scientist, and Medical Director of the Barlo Multiple Sclerosis (MS) Program at St. Michael’s Hospital, University of Toronto. Dr. Oh’s research focuses on developing advanced MRI techniques in the spinal cord and brain for use in clinical settings. She leads the MRI research program at St. Michael’s Hospital, and is the principal investigator on numerous local and multi-center collaborative studies, including the Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo), which is a national prospective cohort study designed to better understand progression in MS.

Recent Publications

  1. Freedman, DE, Oh, J, Feinstein, A. Predictors of Antidepressant Use Among People With Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 2025; :appineuropsych20240096. doi: 10.1176/appi.neuropsych.20240096. PubMed PMID:39885723 .
  2. Jia, A, Kuramoto, L, Khakban, A, Sio, WS, Traboulsee, A, De Vera, MA et al.. Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol. BMJ Open. 2025;15 (1):e088924. doi: 10.1136/bmjopen-2024-088924. PubMed PMID:39855661 PubMed Central PMC11759199.
  3. Martin, ML, Cao, Q, Luskin, E, Renner, B, Daboul, L, O'Donnell, CM et al.. Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter Study. J Neuroimaging. 2025;35 (1):e70011. doi: 10.1111/jon.70011. PubMed PMID:39838609 .
  4. Freedman, DE, Oh, J, Feinstein, A. Not for everyone: Factors influencing who receives psychotherapy in people with multiple sclerosis. Mult Scler Relat Disord. 2025;94 :106245. doi: 10.1016/j.msard.2024.106245. PubMed PMID:39764908 .
  5. Laakso, SM, Oh, J, Raufdeen, F, Jones, A, Reiskanen, H, Feb, K et al.. Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic implications from a multicenter cohort. Mult Scler. 2024; :13524585241309257. doi: 10.1177/13524585241309257. PubMed PMID:39727322 .
  6. Dal-Bianco, A, Oh, J, Sati, P, Absinta, M. Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance. Ther Adv Neurol Disord. 2024;17 :17562864241306684. doi: 10.1177/17562864241306684. PubMed PMID:39711984 PubMed Central PMC11660293.
  7. Androdias, G, Lünemann, JD, Maillart, E, Amato, MP, Audoin, B, Bruijstens, AL et al.. De-escalating and discontinuing disease-modifying therapies in multiple sclerosis. Brain. 2024; :. doi: 10.1093/brain/awae409. PubMed PMID:39707906 .
  8. Latypov, TH, Wolfensohn, A, Yakubov, R, Li, J, Srisaikaew, P, Jörgens, D et al.. Signatures of chronic pain in multiple sclerosis: a machine learning approach to investigate trigeminal neuralgia. Pain. 2024; :. doi: 10.1097/j.pain.0000000000003497. PubMed PMID:39680491 .
  9. Amin, M, Nakamura, K, Daboul, L, O'Donnell, C, Cao, Q, Rodrigues, P et al.. Incorporation of the central vein sign into the McDonald criteria. Mult Scler Relat Disord. 2025;93 :106182. doi: 10.1016/j.msard.2024.106182. PubMed PMID:39622133 PubMed Central PMC11779579.
  10. Keegan, BM, Absinta, M, Cohen-Adad, J, Flanagan, EP, Henry, RG, Klawiter, EC et al.. Spinal cord evaluation in multiple sclerosis: clinical and radiological associations, present and future. Brain Commun. 2024;6 (6):fcae395. doi: 10.1093/braincomms/fcae395. PubMed PMID:39611182 PubMed Central PMC11604059.
Search PubMed

Affiliations & Other Activities

  • Staff Neurologist, Division of Neurology, Department of Medicine, St. Michael’s Hospital
  • Associate Professor, Department of Medicine, University of Toronto
  • Adjunct Faculty, Department of Neurology, Johns Hopkins University